Trial Profile
Exploratory clinical trial of the new third line Helicobacter pylori eradication therapy using vonoprazan
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2018
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Amoxicillin; Sitafloxacin
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 04 Sep 2015 New trial record